Resveratrol repressed viability of U251 cells by miR-21 inhibiting of NF-κB pathway

Molecular and Cellular Biochemistry

Volumn 382, Issue 1-2, 2013, Pages 137-143

  Li, Hongxiu ^a   Jia, Zhijun ^b   Li, Aimei ^b   Jenkins, Gareth ^c   Yang, Xin ^c   Hu, Jun ^a   Guo, Wanhua ^b  

^a Ningbo Mingzhou Hospital   (China)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^c NANJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Apoptosis; Glioma; miR 21; NF B; Resveratrol

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 21; RESVERATROL;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG TARGETING; FLOW CYTOMETRY; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL; WESTERN BLOTTING;

RICE STRIPE VIRUS;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NF-KAPPA B; SIGNAL TRANSDUCTION; STILBENES;

EID: 84884673564     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1728-1     Document Type: Article

References (23)

1. Khan MK, Hunter GK, Vogelbaum M, Suh JH, Chao ST (2009) Evidence-based adjuvant therapy for gliomas: current concepts and newer developments. Indian J Cancer 46:96-107
2. Sathornsumetee S, Rich JN (2006) New approaches to primary brain tumor treatment. Anticancer Drugs 17:1003-1016
3. Harikumar KB, Aggarwal BB (2008) Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7:1020-1035
4. Borriello A, Cucciolla V, Della Raqione F, Galletti P (2010) Dietary polyphenols: focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis. Nutr Metab Cardiovasc Dis 20:618-625
5. Albani D, Polito L, Forloni G (2010) Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence. J Alzheimers Dis 19:11-26
6. Jiang H, Shang X, Wu H, Huang G, Wang Y, Al-Holou S, Gautam SC, Chopp M (2010) Combination treatment with resveratrol and sulforaphane induces apoptosis in human U251 glioma cells. Neurochem Res 35:152-161
7. Castino R, Pucer A, Veneroni R, Morani F, Peracchio C, Lah TT, Isidoro C (2011) Resveratrol reduces the invasive growth and promotes the acquisition of a long-lasting differentiated phenotype in human glioblastoma cells. J Agric Food Chem 59:4264-4272
8. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
9. Winter J, Jung S, Keller S, Gregory RI, Diederich S (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11:228-234
10. Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65(14):6029-6033
11. Li Y, Li W, Yang Y, Lu Y, He C, Hu G, Liu H, Chen J, He J, Yu H (2009) MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. Brain Res 1286:13-18
12. Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R, Shah K (2007) MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 67:8994-9000
13. Nakabayashi H, Shimizu K (2012) Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo. BMC Cancer 12:453-463
14. Dutta J, Fan Y, Gupta N, Fan G, Gélinas C (2006) Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene 25:6800-6816
15. Gagliano N, Aldini G, Colombo G, Rossi R, Colombo R, Gioia M, Milzani A, Dalle-Donne I (2010) The potential of resveratrol against human gliomas. Anticancer Drugs 21:140-150
16. Ma T, Zhu ZG, Ji YB, Zhang Y, Yu YY, Liu BY, Yin HR, Lin YZ (2004) Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2′-deoxyuridine. World J Gastroenterol 10:172-176
17. Vermes I, Haanen C, Reutelingsperger C (2000) Flow cytometry of apoptotic cell death. J Immunol Methods 243:167-190
18. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, Gerritsen ME (1997) Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272:21096-21103
19. Chen LF, Greene WC (2004) Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5:392-401
20. Inoue J, Gohda J, Akiyama T, Semba K (2007) NF-kappaB activation in development and progression of cancer. Cancer Sci 98:268-274
21. Nogueira L, Ruiz-Ontañon P, Vazquez-Barquero A, Moris F, Fernandez-Luna JL (2011) The NF-κB pathway: a therapeutic target in glioblastoma. Oncotarget 2(8):646-653
22. Huang H, Lin H, Zhang X, Li J (2012) Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-κB-dependent pathway. Oncol Rep 27(6):2050-2056
23. Shi L, Chen J, Yang J, Pan T, Zhang S, Wang Z (2010) MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Brain Res 1352:255-264